NIH Clinical Center: Search the Studies

Search the Studies

12 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.

Protocol Number	Title	Protocol Status	Min-Max Age	Institute	Keywords
000760-H	Extension Study (extended access) of Syk-inhibition Using Fostamatinib to Treat Post-Transplant Immune-mediated Cytopenias	Enrolling by Invitation	18-75 Years	NHLBI	Thrombocytopenia
000758-H	A Phase II Study Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-Mediated Cytopenias	Participants currently recruited/enrolled	18-75 Years	NHLBI	Thrombocytopenia
20-H-0033	Early Initiation of Oral Therapy with Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)	Participants currently recruited/enrolled	3-125 Years	NHLBI	Thrombocytopenia
19-CC-0005	Short or Long Infusion Duration for Platelets: The SOLID Platelet Study	Participants currently recruited/enrolled	18-100 Years	CC	Thrombocytopenia
13-H-0133	Extended Dosing with Eltrombopag in Refractory Severe Aplastic Anemia	Completed Study; data analyses ongoing	2-125 Years	NHLBI	Thrombocytopenia
12-H-0150	Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia	Participants currently recruited/enrolled	2-125 Years	NHLBI	Thrombocytopenia
11-H-0134	A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Moderate Aplastic Anemia Patients	No longer recruiting/follow-up only	2-125 Years	NHLBI	Thrombocytopenia
09-I-0126	Pathogenesis and Genetic Basis of Physical Induced Urticarial Syndromes	Participants currently recruited/enrolled	2-90 Years	NIAID	Thrombocytopenia
09-H-0199	A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R agonist), Eltrombopag, in Patients with Low to Int-2 Risk Myelodysplastic Syndrome (MDS)	Completed Study; data analyses ongoing	18-125 Years	NHLBI	Thrombocytopenia
05-H-0242	A Pilot Study of Alemtuzumab (Campath) in Patients with Relapsed or Refractory Severe Aplastic Anemia	Completed Study; data analyses ongoing	2-110 Years	NHLBI	Thrombocytopenia
02-C-0052	Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study	Participants currently recruited/enrolled	0-125 Years	NCI	Thrombocytopenia
97-H-0041	Screening Protocol for Subjects Being Evaluated for National Heart, Lung and Blood Institute (NHLBI) Protocols	Enrolling by Invitation	2-125 Years	NHLBI	Thrombocytopenia